Envista (NYSE:NVST – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.950-1.050 for the period, compared to the consensus earnings per share estimate of 1.120. The company issued revenue guidance of -.
Analyst Ratings Changes
A number of research firms have issued reports on NVST. Jefferies Financial Group boosted their target price on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Piper Sandler increased their price objective on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday. Stifel Nicolaus raised their target price on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and upped their price target for the company from $16.00 to $23.00 in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Envista currently has a consensus rating of “Hold” and a consensus target price of $20.21.
Read Our Latest Report on Envista
Envista Stock Performance
Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Research analysts anticipate that Envista will post 0.72 EPS for the current fiscal year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- 3 Healthcare Dividend Stocks to Buy
- 3 Must-Have ETFs Set to Dominate This Quarter
- The Risks of Owning Bonds
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Learn Technical Analysis Skills to Master the Stock Market
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.